[go: up one dir, main page]

ES2062271T3 - Preparaciones farmaceuticas. - Google Patents

Preparaciones farmaceuticas.

Info

Publication number
ES2062271T3
ES2062271T3 ES90122574T ES90122574T ES2062271T3 ES 2062271 T3 ES2062271 T3 ES 2062271T3 ES 90122574 T ES90122574 T ES 90122574T ES 90122574 T ES90122574 T ES 90122574T ES 2062271 T3 ES2062271 T3 ES 2062271T3
Authority
ES
Spain
Prior art keywords
sub
weight
pharmaceutical preparations
tetrahydrofurfuril
polyloxyethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90122574T
Other languages
English (en)
Inventor
Walter Fries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MACK CHEM PHARM
Heinrich Mack Nachf GmbH and Co
Original Assignee
MACK CHEM PHARM
Heinrich Mack Nachf GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MACK CHEM PHARM, Heinrich Mack Nachf GmbH and Co filed Critical MACK CHEM PHARM
Application granted granted Critical
Publication of ES2062271T3 publication Critical patent/ES2062271T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UNA PREPARACION FARMACEUTICA PARA ADMINISTRACION PARENTERAL DE UNA DROGA QUE CONSISTE EN UN SISTEMA DISOLVENTE QUE CONTIENE: (A) DEL 0 AL 65 % DE SU PESO DE A-TETRAHIDROFURFURIL-W-HIDROXI -POLILOXIETILENO; (B) DEL 10 AL 100 % DE SU PESO DE GLICOL POLIETILENO CON UN PESO MEDIO MOLECULAR DE 200 A 600; Y (C) DEL 0 AL 35 % DE SU PESO DE AGUA. LA SUMA DE LOS COMPONENTES (A) Y (B) QUE ASCIENDE HASTA AL MENOS EL 65 % DE SU PESO, Y DE UNO O MAS COMPUESTOS TERAPEUTICAMENTE ACTIVOS DE LA FORMULA DONDE R SUB 1 DENOTA UN RADICAL FENILICO SUSTITUIDO OPCIONALMENTE POR 1 A 3 SUSTITUTOS SELECCIONADOS INDEPENDIENTEMENTE DE UN GRUPO CONSTITUIDO POR F, CL, BR, I, CF SUB 3, C SUB 1 A C SUB 4 ALKIL Y C SUB 1 A C SUB 4 ALKOXI , O 5-CLOROPIRIDIO-2-YL; X DENOTA OH, F, CL O BR; R SUB 2 ES H, CH SUB 3 O F; Y R SUB 3 ES H O F.
ES90122574T 1989-11-29 1990-11-26 Preparaciones farmaceuticas. Expired - Lifetime ES2062271T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
ES2062271T3 true ES2062271T3 (es) 1994-12-16

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90122574T Expired - Lifetime ES2062271T3 (es) 1989-11-29 1990-11-26 Preparaciones farmaceuticas.

Country Status (29)

Country Link
US (1) US5118698A (es)
EP (1) EP0430149B1 (es)
JP (1) JPH0660097B2 (es)
KR (1) KR940000066B1 (es)
CN (1) CN1035357C (es)
AT (1) ATE102051T1 (es)
AU (1) AU626480B2 (es)
BR (1) BR9006025A (es)
CA (1) CA2030911C (es)
CY (1) CY1970A (es)
CZ (1) CZ282898B6 (es)
DE (2) DE3939492A1 (es)
DK (1) DK0430149T3 (es)
EG (1) EG19557A (es)
ES (1) ES2062271T3 (es)
FI (1) FI103713B1 (es)
HK (1) HK216896A (es)
HU (1) HU220867B1 (es)
IE (1) IE64672B1 (es)
IL (1) IL96450A (es)
MX (1) MX23518A (es)
MY (1) MY104540A (es)
NO (1) NO180475C (es)
NZ (1) NZ236255A (es)
PT (1) PT96003B (es)
RU (1) RU2038080C1 (es)
SK (1) SK280599B6 (es)
YU (1) YU227290A (es)
ZA (1) ZA909549B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
WO2002067899A1 (en) * 2001-02-28 2002-09-06 Akzo Nobel N.V. Injectable water-in-oil emulsions
AU2003210517A1 (en) 2002-02-04 2003-09-02 Elan Pharma International, Ltd. Drug nanoparticles with lysozyme surface stabiliser
EP1551457A1 (en) * 2002-07-16 2005-07-13 Elan Pharma International Limited Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (es) * 1982-06-09 1984-10-22 Pfizer
DK476385A (da) * 1984-10-19 1986-04-20 Schering Corp 1,3-bis(1h-1,2,4-triazol-1-yl)-2-flour-2-(2,4-difluorphenyl)propan, antifungale midler indeholdende denne forbindelse, og fremgangsmaade til fremstilling af denne forbindelse

Also Published As

Publication number Publication date
CN1035357C (zh) 1997-07-09
CA2030911C (en) 1995-02-07
FI905814L (fi) 1991-05-30
DE3939492A1 (de) 1991-06-06
CN1052046A (zh) 1991-06-12
DK0430149T3 (da) 1994-03-28
EP0430149B1 (en) 1994-03-02
DE69007029T2 (de) 1994-06-09
JPH03176421A (ja) 1991-07-31
IL96450A (en) 1994-10-21
KR910009286A (ko) 1991-06-28
IE904282A1 (en) 1991-06-05
HU220867B1 (en) 2002-06-29
HUT57039A (en) 1991-11-28
FI103713B (fi) 1999-08-31
KR940000066B1 (ko) 1994-01-05
PT96003B (pt) 1998-01-30
NO180475B (no) 1997-01-20
EG19557A (en) 1997-08-31
YU227290A (sh) 1993-10-20
CZ282898B6 (cs) 1997-11-12
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
FI905814A0 (fi) 1990-11-26
ATE102051T1 (de) 1994-03-15
NO180475C (no) 1997-04-30
RU2038080C1 (ru) 1995-06-27
AU626480B2 (en) 1992-07-30
EP0430149A2 (en) 1991-06-05
CA2030911A1 (en) 1991-05-30
JPH0660097B2 (ja) 1994-08-10
NZ236255A (en) 1992-02-25
EP0430149A3 (en) 1991-09-25
NO905106L (no) 1991-05-30
US5118698A (en) 1992-06-02
SK595390A3 (en) 2000-04-10
HK216896A (en) 1996-12-27
PT96003A (pt) 1991-09-13
CY1970A (en) 1997-09-05
AU6706590A (en) 1991-08-08
MX23518A (es) 1993-04-01
IE64672B1 (en) 1995-08-23
SK280599B6 (sk) 2000-04-10
NO905106D0 (no) 1990-11-26
ZA909549B (en) 1992-06-24
MY104540A (en) 1994-04-30
BR9006025A (pt) 1991-09-24
CZ595390A3 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
ES2193142T3 (es) Uso de benzotiofenos para el tratamiento de hipercolesterolemia.
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
DE69008012D1 (de) 4-Fluorbenzolderivate, Herstellungsverfahren und diese enthaltende pharmazeutische Zusammensetzungen.
ES503768A0 (es) Procedimiento de preparacion de derivados de 1-fenil-1-hi- droxi-etilamina
ES2113413T3 (es) Derivados antiviricos del acido 2-desoxi-2,3-didehidro alfa-d-neuraminico 4 substituido.
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
SE8600632D0 (sv) Novel pharmaceutical composition
DE69312984D1 (de) Substituierte Aminophosphonatderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ES2062271T3 (es) Preparaciones farmaceuticas.
ES2133295T3 (es) Peptidos ciclicos y su uso.
ES2039213T3 (es) Procedimiento para producir nuevos compuestos relacionados con espergualina.
FI833200A (fi) Isokinolinderivat, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutpreparat och deras anvaendning
ATE63563T1 (de) Synergistin-derivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IT1222734B (it) Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
HUP9802096A2 (hu) Piperidino-alkanol-vegyületeket tartalmazó orális adagolású oldat formájú gyógyszerkészítmény, és eljárás előállítására
ES2060592T3 (es) Un tioester y su uso en la preparacion de composiciones farmaceuticas para el tratamiento de los sindromes de isquemia y reperfusion.
DE3676378D1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
ES8405794A1 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
MX9203068A (es) Compuestos activirales oralmente activos.
AR029415A1 (es) Pirroles sustituidos, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos compuestos para la preparacion de medicamentos
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
SE8204791L (sv) Sett att framstella alkoxivinkaminsyraestrar och alkoxiapovinkaminsyraestrar

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 430149

Country of ref document: ES